A presentation at the October conference of the Society for Integrative Oncology in Scottsdale, Arizona, revealed that daily use of the AHCC supplement could support the host immune system to eradicate HPV infection in women.
Results from an ongoing clinical trial evaluating AHCC for the treatment of HPV indicated that close to 60 percent of the patients showed no signs of the infection at six months of treatment. The randomized, double-blind, placebo-controlled study is following 50 women for up to 12 months, with one group taking six 500-mg capsules of AHCC and a second group receiving placebo.
Currently, there is no standard of care for persistent, high-risk HPV infections. AHCC is a natural, immune-modulating compound derived from specially cultured medicinal mushroom roots. The supplement is well-tolerated in patients who receive it and studies indicate that it works by increasing the number and/or activity of natural killer (NK) cells, killer T-cells, dendritic cells, and cytokines. This enables the body to effectively fight infections.
Multiple studies have demonstrated that AHCC improves the quality of life of cancer patients. In addition, the supplement has been shown to reduce viral loads in patients with hepatitis C as well as helping patients with non-viral liver disease.
Source: BioSpace.com, November 5, 2018